Clinical trials to prevent restenosis after percutaneous coronary revascularization.

about

Stent development and local drug delivery.Radiation medicine innovations for the new millenium.Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty.

P2860

Q34470332-16126712-895C-469C-BA9D-25EAAA116AA1 Q35091845-3D57A86C-0B5A-4727-B67F-7E1752267D87 Q43737910-84BFFA04-17D4-45D5-9311-52A05287C122

P2860

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

Item

http://www.wikidata.org/entity/Q41500665

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

@en

type

Item

label

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

@en

prefLabel

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

@en

P1476

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

@en

P2093

Mak KH

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

Integrins: versatility, modulation, and signaling in cell adhesion

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits.

Elevated serum lipoprotein(a) is a risk factor for clinical recurrence after coronary balloon angioplasty.

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.

P304

255-84; discussion 284-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1749-6632.1997.TB52007.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

811

http://www.w3.org/2001/XMLSchema#string

P50

Eric Topol

P577

1997-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9186603

http://www.w3.org/2001/XMLSchema#string

P921

revascularization

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

about

P2860

P2860

Clinical trials to prevent restenosis after percutaneous coronary revascularization.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921